Unknown OBSERVATIONAL NCT00672269

Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors

A Pilot Study to Investigate Germ-Line MEN1 and SDHD Gene Mutation in Familial Cases of Carcinoid Cancer

Sponsor: Rutgers University

Conditions Carcinoid Neuroendocrine Cancer

Updated 10 times since 2017 Last updated: Feb 3, 2009 Started: Apr 30, 2008 Primary completion: Apr 30, 2009 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00672269, this observational or N/A phase trial focuses on Carcinoid Neuroendocrine Cancer and remains ongoing. Sponsored by Rutgers University, it has been updated 10 times since 2008, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Unknown Status NA
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rutgers University

Data source: Rutgers University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Piscataway, United States